Clinical Orthopaedics and Related Research®

, Volume 471, Issue 3, pp 891–898 | Cite as

Adult Soft Tissue Sarcoma Local Recurrence After Adjuvant Treatment Without Resection of Core Needle Biopsy Tract

  • Odion Binitie
  • Shawn Tejiram
  • Sheila Conway
  • David Cheong
  • H. Thomas Temple
  • G. Douglas Letson
Symposium: Highlights from the First Combined 2011 Meeting of the Musculoskeletal Tumor Society and Connective Tissue Oncology Society



Core needle biopsies of sarcomas allow a diagnosis in a high percentage of patients with few complications. However, it is unclear whether the tract needs to be excised to prevent recurrences.


We therefore determined the rates of recurrence and metastases in patients with Stage III extremity sarcomas, who underwent wide local resection without excision of the needle tract and also received adjuvant treatment.


We retrospectively reviewed 59 adult patients with deep, larger than 5 cm, high-grade soft tissue sarcomas of the upper or lower extremity treated between January 1999 and April 2009. All the patients underwent a core needle biopsy. Resection was performed with wide margins. The biopsy tract was not resected during the definitive surgery. Fifty-seven patients (97%) received preoperative and/or postoperative radiation, whereas 49 patients (83%) received chemotherapy. Local recurrence and distant recurrence rates were determined. The minimum followup was 24 months (median, 56 months; range, 24–122 months).


The local recurrence rate was 9%. Fifteen patients (25%) developed metastasis after diagnosis. Seven of the 59 patients (12%) had microscopic positive margins at resection.


Our data demonstrate no increase in local recurrence rates or rates of metastatic disease compared with previously published studies when resection of the core biopsy tract was not performed.

Level of Evidence

Level IV, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.


  1. 1.
    Adams SC, Potter BK, Pitcher DJ, Temple HT. Office-based core needle biopsy of bone and soft tissue malignancies: an accurate alternative to open biopsy with infrequent complications. Clin Orthop Relat Res. 2010;468:274–2780.CrossRefGoogle Scholar
  2. 2.
    Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults. Cochrane Database Syst Rev. 2000;4:CD001419.Google Scholar
  3. 3.
    Alektiar KM, Velasco J, Zelefsky MJ, Woodruff JM, Lewis JJ, Brennan MF. Adjuvant radiotherapy for margin-positive high-grade soft tissue sarcoma of the extremity. Int J Radiat Oncol Biol Phys. 2000;48:1051–1058.PubMedCrossRefGoogle Scholar
  4. 4.
    Alkis N, Muallaoglu S, Kocer M, Arslan UY, Durnali AG, Tokluoglu S, Celenkoglu G, Paksoy F, Coskun U. Primary adult soft tissue sarcomas: analysis of 294 patients. Med Oncol. 2011;28:391–39.PubMedCrossRefGoogle Scholar
  5. 5.
    Altuntas AO, Slavin J, Smith PJ, Schlict SM, Powell GJ, Ngan S, Toner G, Choong PF. Accuracy of computed tomography guided core needle biopsy of musculoskeletal tumours. A N Z J Surg. 2005;75:187–191.CrossRefGoogle Scholar
  6. 6.
    American Cancer Society. Cancer Facts and Figures 2010. Atlanta, GA, USA: American Cancer Society; 2010.Google Scholar
  7. 7.
    Ball AB, Fisher C, Pittam M, Watkins RM, Westbury G. Diagnosis of soft tissue tumours by Tru-Cut biopsy. Br J Surg. 1990;77:756–758.PubMedCrossRefGoogle Scholar
  8. 8.
    Bell RS, O’Sullivan B, Liu FF, Powell J, Langer F, Fornasier VL, Cummings B, Miceli PN, Hawkins N, Quirt I, et al. The surgical margin in soft-tissue sarcoma. J Bone Joint Surg Am. 1989;71:370–375.PubMedGoogle Scholar
  9. 9.
    Canter RJ, Beal S, Borys D, Martinez SR, Bold RJ, Robbins AS. Interaction of histologic subtype and histologic grade in predicting survival for soft-tissue sarcomas. J Am Coll Surg. 2010;210:191–198.PubMedCrossRefGoogle Scholar
  10. 10.
    Carrino JA, Khurana B, Ready JE, Silverman SG, Winalski CS. Magnetic resonance imaging-guided percutaneous biopsy of musculoskeletal lesions. J Bone Joint Surg Am. 2007;89:2179–2187.PubMedCrossRefGoogle Scholar
  11. 11.
    Chen YJ, Chang GC, Chen WH, Hsu HC, Lee TS. Local metastases along the tract of needle: a rare complication of vertebroplasty in treating spinal metastases. Spine (Phila Pa 1976). 2007;32:615–618.CrossRefGoogle Scholar
  12. 12.
    Cheng EY, Dusenbery KE, Winters MR, Thompson RC. Soft tissue sarcomas: preoperative versus postoperative radiotherapy. J Surg Oncol. 1996;61:90–99.PubMedCrossRefGoogle Scholar
  13. 13.
    Coindre JM, Terrier P, Bui NB, Bonichon F, Collin F, Le Doussal V, Mandard AM, Vilain MO, Jacquemier J, Duplay H, Sastre X, Barlier C, Henry-Amar M, Mace-Lesech J, Contesso G. Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol. 1996;14:869–877.PubMedGoogle Scholar
  14. 14.
    Coindre JM, Trojani M, Contesso G, David M, Rouesse J, Bui NB, Bodaert A, De Mascarel I, De Mascarel A, Goussot JF. Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer. 1986;58:306–309.PubMedCrossRefGoogle Scholar
  15. 15.
    Davies NM, Livesley PJ, Cannon SR. Recurrence of an osteosarcoma in a needle biopsy track. J Bone Joint Surg Br. 1993;75:977–978.PubMedGoogle Scholar
  16. 16.
    Davis AM, O’Sullivan B, Turcotte R, Bell R, Catton C, Chabot P, Wunder J, Hammond A, Benk V, Kandel R, Goddard K, Freeman C, Sadura A, Zee B, Day A, Tu D, Pater J. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol. 2005;75:48–53.PubMedCrossRefGoogle Scholar
  17. 17.
    Dupuy DE, Rosenberg AE, Punyaratabandhu T, Tan MH, Mankin HJ. Accuracy of CT-guided needle biopsy of musculoskeletal neoplasms. AJR Am J Roentgenol. 1998;171:759–762.PubMedGoogle Scholar
  18. 18.
    Eilber FC, Rosen G, Nelson SD, Selch M, Dorey F, Eckardt J, Eilber FR. High-grade extremity soft tissue sarcomas: factors predictive of local recurrence and its effect on morbidity and mortality. Ann Surg. 2003;237:218–226.PubMedGoogle Scholar
  19. 19.
    Figueredo A, Bramwell VH, Bell R, Davis AM, Charette ML, the Members of the Cancer Care Ontario Practice Guidelines Initiative Sarcoma Disease Site Group. Adjuvant chemotherapy following complete resection of soft tissue sarcoma in adults: a clinical practice guideline. Sarcoma. 2002;6:5–18.PubMedCrossRefGoogle Scholar
  20. 20.
    Fitzal F, Sporn EP, Draxler W, Mittlbock M, Taucher S, Rudas M, Riedl O, Helbich TH, Jakesz R, Gnant M. Preoperative core needle biopsy does not increase local recurrence rate in breast cancer patients. Breast Cancer Res Treat. 2006;97:9–15.PubMedCrossRefGoogle Scholar
  21. 21.
    Fowler N, Asatiani E, Cheson B. Needle tract seeding after bone marrow biopsy in non-Hodgkin lymphoma. Leuk Lymphoma. 2008;49:156–158.PubMedCrossRefGoogle Scholar
  22. 22.
    Gronchi A, Lo Vullo S, Colombo C, Collini P, Stacchiotti S, Mariani L, Fiore M, Casali PG. Extremity soft tissue sarcoma in a series of patients treated at a single institution: local control directly impacts survival. Ann Surg. 2010;251:506–511.PubMedCrossRefGoogle Scholar
  23. 23.
    Herbert SH, Corn BW, Solin LJ, Lanciano RM, Schultz DJ, McKenna WG, Coia LR. Limb-preserving treatment for soft tissue sarcomas of the extremities. The significance of surgical margins. Cancer. 1993;72:1230–1238.PubMedCrossRefGoogle Scholar
  24. 24.
    Heslin MJ, Lewis JJ, Woodruff JM, Brennan MF. Core needle biopsy for diagnosis of extremity soft tissue sarcoma. Ann Surg Oncol. 1997;4:425–431.PubMedCrossRefGoogle Scholar
  25. 25.
    Heslin MJ, Woodruff J, Brennan MF. Prognostic significance of a positive microscopic margin in high-risk extremity soft tissue sarcoma: implications for management. J Clin Oncol. 1996;14:473–478.PubMedGoogle Scholar
  26. 26.
    Ito Y, Asahi S, Matsuzuka F, Nakamura Y, Amino N, Miyauchi A. Needle tract implantation of follicular neoplasm after fine-needle aspiration biopsy: report of a case. Thyroid. 2006;16:1059–1062.PubMedCrossRefGoogle Scholar
  27. 27.
    Jebsen NL, Trovik CS, Bauer HC, Rydholm A, Monge OR, Hall KS, Alvegard T, Bruland OS. Radiotherapy to improve local control regardless of surgical margin and malignancy grade in extremity and trunk wall soft tissue sarcoma: a Scandinavian sarcoma group study. Int J Radiat Oncol Biol Phys. 2008;71:1196–1203.PubMedCrossRefGoogle Scholar
  28. 28.
    Kaffenberger BH, Wakely PE Jr, Mayerson JL. Local recurrence rate of fine-needle aspiration biopsy in primary high-grade sarcomas. J Surg Oncol. 2010;101:618–621.PubMedCrossRefGoogle Scholar
  29. 29.
    Karwowski JK, Nowels KW, McDougall IR, Weigel RJ. Needle track seeding of papillary thyroid carcinoma from fine needle aspiration biopsy. A case report. Acta Cytol. 2002;46:591–595.PubMedCrossRefGoogle Scholar
  30. 30.
    Khanfir K, Alzieu L, Terrier P, Le Pechoux C, Bonvalot S, Vanel D, Le Cesne A. Does adjuvant radiation therapy increase loco-regional control after optimal resection of soft-tissue sarcoma of the extremities? Eur J Cancer. 2003;39:1872–1880.PubMedCrossRefGoogle Scholar
  31. 31.
    Kim JE, Kim CY, Kim DG, Jung HW. Implantation metastasis along the stereotactic biopsy tract in anaplastic astrocytoma: a case report. J Neurooncol. 2003;61:215–218.PubMedCrossRefGoogle Scholar
  32. 32.
    Kissin MW, Fisher C, Carter RL, Horton LW, Westbury G. Value of Tru-cut biopsy in the diagnosis of soft tissue tumours. Br J Surg. 1986;73:742–744.PubMedCrossRefGoogle Scholar
  33. 33.
    Koea JB, Leung D, Lewis JJ, Brennan MF. Histopathologic type: an independent prognostic factor in primary soft tissue sarcoma of the extremity? Ann Surg Oncol. 2003;10:432–440.PubMedCrossRefGoogle Scholar
  34. 34.
    Lewis JJ, Leung D, Heslin M, Woodruff JM, Brennan MF. Association of local recurrence with subsequent survival in extremity soft tissue sarcoma. J Clin Oncol. 1997;15:646–652.PubMedGoogle Scholar
  35. 35.
    Mankin HJ, Lange TA, Spanier SS. The Classic: the hazards of biopsy in patients with malignant primary bone and soft-tissue tumors. The Journal of Bone and Joint Surgery, 1982;64:1121–1127. Clin Orthop Relat Res. 2006;450:4–10.PubMedCrossRefGoogle Scholar
  36. 36.
    Massi D, Beltrami G, Mela MM, Pertici M, Capanna R, Franchi A. Prognostic factors in soft tissue leiomyosarcoma of the extremities: a retrospective analysis of 42 cases. Eur J Surg Oncol. 2004;30:565–572.PubMedCrossRefGoogle Scholar
  37. 37.
    McKee MD, Liu DF, Brooks JJ, Gibbs JF, Driscoll DL, Kraybill WG. The prognostic significance of margin width for extremity and trunk sarcoma. J Surg Oncol. 2004;85:68–76.PubMedCrossRefGoogle Scholar
  38. 38.
    Mendenhall WM, Indelicato DJ, Scarborough MT, Zlotecki RA, Gibbs CP, Mendenhall NP, Mendenhall CM, Enneking WF. The management of adult soft tissue sarcomas. Am J Clin Oncol. 2009;32:436–442.PubMedCrossRefGoogle Scholar
  39. 39.
    Mitsuyoshi G, Naito N, Kawai A, Kunisada T, Yoshida A, Yanai H, Dendo S, Yoshino T, Kanazawa S, Ozaki T. Accurate diagnosis of musculoskeletal lesions by core needle biopsy. J Surg Oncol. 2006;94:21–27.PubMedCrossRefGoogle Scholar
  40. 40.
    Moore TM, Meyers MH, Patzakis MJ, Terry R, Harvey JP Jr. Closed biopsy of musculoskeletal lesions. J Bone Joint Surg Am. 1979;61:375–380.PubMedGoogle Scholar
  41. 41.
    Ogilvie CM, Torbert JT, Finstein JL, Fox EJ, Lackman RD. Clinical utility of percutaneous biopsies of musculoskeletal tumors. Clin Orthop Relat Res. 2006;450:95–100.PubMedCrossRefGoogle Scholar
  42. 42.
    Pervaiz N, Colterjohn N, Farrokhyar F, Tozer R, Figueredo A, Ghert M. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer. 2008;113:573–581.PubMedCrossRefGoogle Scholar
  43. 43.
    Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol. 1996;14:1679–1689.PubMedGoogle Scholar
  44. 44.
    Ramanathan RC, A’Hern R, Fisher C, Thomas JM. Prognostic index for extremity soft tissue sarcomas with isolated local recurrence. Ann Surg Oncol. 2001;8:278–289.PubMedCrossRefGoogle Scholar
  45. 45.
    Rosenberg SA, Tepper J, Glatstein E, Costa J, Young R, Baker A, Brennan MF, Demoss EV, Seipp C, Sindelar WF, Sugarbaker P, Wesley R. Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities. Cancer. 1983;52:424–434.PubMedCrossRefGoogle Scholar
  46. 46.
    Rowe LR, Mulvihill SJ, Emerson L, Gopez EV. Subcutaneous tumor seeding following needle core biopsy of hepatocellular carcinoma. Diagn Cytopathol. 2007;35:717–721.PubMedCrossRefGoogle Scholar
  47. 47.
    Rubin BP, Cooper K, Fletcher CDM, Folpe AL, Gannon FH, Leigh Hunt J, Lazar AJ, Montag AG, Peabody TD, Pollock RE, Qualman SJ, Reith JD, Rosenberg AE, Weiss SW, Krausz T; Members of the Cancer Committee, College of American Pathologists. Protocol for the examination of specimens from patients with tumors of the soft tissue. Arch Pathol Lab Med. 2010;134:e31–39.PubMedGoogle Scholar
  48. 48.
    Skrzynski MC, Biermann JS, Montag A, Simon MA. Diagnostic accuracy and charge-savings of outpatient core needle biopsy compared with open biopsy of musculoskeletal tumors. J Bone Joint Surg Am. 1996;78:644–649.PubMedGoogle Scholar
  49. 49.
    Soft tissue sarcoma. AJCC Cancer Staging Manual. 7th ed. New York, NY, USA: Springer; 2010:291–296.Google Scholar
  50. 50.
    Stojadinovic A, Leung DH, Allen P, Lewis JJ, Jaques DP, Brennan MF. Primary adult soft tissue sarcoma: time-dependent influence of prognostic variables. J Clin Oncol. 2002;20:4344–4352.PubMedCrossRefGoogle Scholar
  51. 51.
    Stojadinovic A, Leung DH, Hoos A, Jaques DP, Lewis JJ, Brennan MF. Analysis of the prognostic significance of microscopic margins in 2084 localized primary adult soft tissue sarcomas. Ann Surg. 2002;235:424–434.PubMedCrossRefGoogle Scholar
  52. 52.
    Strander H, Turesson I, Cavallin-Stahl E. A systematic overview of radiation therapy effects in soft tissue sarcomas. Acta Oncol. 2003;42:516–531.PubMedCrossRefGoogle Scholar
  53. 53.
    Suit HD, Mankin HJ, Wood WC, Proppe KH. Preoperative, intraoperative, and postoperative radiation in the treatment of primary soft tissue sarcoma. Cancer. 1985;55:2659–2667.PubMedCrossRefGoogle Scholar
  54. 54.
    Suzuki K, Takamochi K, Funai K, Kazui T. Needle tract implantation clearly visualized by computed tomography following needle biopsy of malignant mesothelioma. Eur J Cardiothorac Surg. 2006;29:1051.PubMedCrossRefGoogle Scholar
  55. 55.
    Tanabe K, Pollock R, Ellis L, Murphy A, Sherman N, Romsdahl M. Influence of surgical margins on outcome in patients with preoperatively irradiated extermity soft tissue sarcomas. Cancer. 1994;73:1652–1659.PubMedCrossRefGoogle Scholar
  56. 56.
    Trovik CS, Bauer HC, Berlin O, Tukiainen E, Erlanson M, Gustafson P, Klepp R, Saeter G, Wahlstrom O. Local recurrence of deep-seated, high-grade, soft tissue sarcoma: 459 patients from the Scandinavian Sarcoma Group Register. Acta Orthop Scand. 2001;72:160–166.PubMedCrossRefGoogle Scholar
  57. 57.
    Trovik CS, Gustafson P, Bauer HC, Saeter G, Klepp R, Berlin O, Erlanson M, Wahlstrom O, Raabe N. Consequences of local recurrence of soft tissue sarcoma: 205 patients from the Scandinavian Sarcoma Group Register. Acta Orthop Scand. 2000;71:488–495.PubMedCrossRefGoogle Scholar
  58. 58.
    Weitz J, Antonescu C, Brennan M. Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time. J Clin Oncol. 2003;21:2719–2725.PubMedCrossRefGoogle Scholar
  59. 59.
    Welker JA, Henshaw RM, Jelinek J, Shmookler BM, Malawer MM. The percutaneous needle biopsy is safe and recommended in the diagnosis of musculoskeletal masses. Cancer. 2000;89:2677–2686.PubMedCrossRefGoogle Scholar
  60. 60.
    Wiklund TA, Alvegard TA, Mouridsen HT, Rydholm A, Blomqvist CP. Marginal surgery and postoperative radiotherapy in soft tissue sarcomas. The Scandinavian Sarcoma Group experience. Eur J Cancer. 1993;29:306–309.CrossRefGoogle Scholar
  61. 61.
    Wu JS, Goldsmith JD, Horwich PJ, Shetty SK, Hochman MG. Bone and soft-tissue lesions: what factors affect diagnostic yield of image-guided core-needle biopsy? Radiology. 2008;248:962–970.PubMedCrossRefGoogle Scholar
  62. 62.
    Yang JC, Chang AE, Baker AR, Sindelar WF, Danforth DN, Topalian SL, DeLaney T, Glatstein E, Steinberg SM, Merino MJ, Rosenberg SA. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol. 1998;16:197–203.PubMedGoogle Scholar
  63. 63.
    Yang YJ, Damron TA. Comparison of needle core biopsy and fine-needle aspiration for diagnostic accuracy in musculoskeletal lesions. Arch Pathol Lab Med. 2004;128:759–764.PubMedGoogle Scholar
  64. 64.
    Yao L, Nelson SD, Seeger LL, Eckardt JJ, Eilber FR. Primary musculoskeletal neoplasms: effectiveness of core-needle biopsy. Radiology. 1999;212:682–686.PubMedGoogle Scholar
  65. 65.
    Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS, Evans HL. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer. 2003;97:2530–2543.PubMedCrossRefGoogle Scholar

Copyright information

© The Association of Bone and Joint Surgeons® 2012

Authors and Affiliations

  • Odion Binitie
    • 1
  • Shawn Tejiram
    • 1
  • Sheila Conway
    • 2
  • David Cheong
    • 1
  • H. Thomas Temple
    • 2
  • G. Douglas Letson
    • 1
  1. 1.H. Lee Moffitt Cancer Center & Research InstituteSarcoma ProgramTampaUSA
  2. 2.Department of Orthopaedics and RehabilitationUniversity of Miami Miller School of MedicineMiamiUSA

Personalised recommendations